Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Mid-Day Market Update: NASDAQ Rises Over 1%; AcelRx Shares Surge After Positive Results From Its Trial On ARX-04

TLPH, APOG, SWKS, LAKE, EXTR, T.EFR, SQNS, VFC

 


Midway through trading Thursday, the Dow traded up 0.81 percent to 18,180.81 while the NASDAQ gained 1.17 percent to 5,234.24. The S&P also rose, gaining 0.84 percent to 2,143.63.

Leading and Lagging Sectors

On Thursday, technology shares gained 1.22 percent. Meanwhile, top gainers in the sector included Skyworks Solutions Inc (NASDAQ: SWKS), and Extreme Networks, Inc (NASDAQ: EXTR).

In trading on Thursday, cyclical consumer goods & services shares rose by just 0.4 percent. Meanwhile, top losers in the sector included Apogee Enterprises Inc (NASDAQ: APOG), down 5 percent, and VF Corp (NYSE: VFC), down 3 percent.

Top Headline

Aerie Pharmaceuticals Inc (NASDAQ: AERI) disclosed that its Phase 3 study of Roclatan met its primary efficacy endpoint.

According to a press release, Roclatan managed to prove statistically superior to each of its components, including the company’s Rhopressa (netarsudil ophthalmic solution) 0.02 percent and the market leading prostaglandin analogue (PGA) latanoprost, in the treatment of patients with maximum baseline intraocular pressures (IOPs) ranging from over 20 to under 36 mmHg (millimeters of mercury).


Equities Trading UP

Lakeland Industries, Inc. (NASDAQ: LAKE) shares shot up 12 percent to $10.49. Lakeland Industries reported Q2 earnings of $0.20 per share on revenue of $22.26 million.

Shares of Aerie Pharmaceuticals Inc (NASDAQ: AERI) got a boost, shooting up 55 percent to $32.71 on news that its Phase 3 study of Roclatan met its primary efficacy endpoint.

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) shares were also up, gaining 11 percent to $3.64 after the company disclosed that its investigational product candidate ARX-04 provided solid tolerance level in an open-label Phase three trial for post operative acute pain treatment.


Equities Trading DOWN

Energy Fuels Inc Ordinary Shares (Canada) (NYSE: UUUU) shares dropped 23 percent to $1.75 after announcing a $10 million bought-deal offering of units.

Shares of Misonix, Inc. (NASDAQ: MSON) were down 18 percent to $5.04 as the company filed for extension of time for its Annual Report on Form 10-K. The company named Joseph Dwyer as interim CFO.

Sequans Communications SA ADR (NYSE: SQNS) was down, falling around 11 percent to $1.70. Sequans priced its offering of 15.152 million shares at $1.65 per ADS.
.


Commodities


In commodity news, oil traded up 0.84 percent to $44.52 while gold traded down 0.31 percent to $1,322.00.

Silver traded up 0.28 percent Thursday to $19.12, while copper rose 0.26 percent to $2.16.

Eurozone

European shares were higher today. The eurozone’s STOXX 600 climbed 0.61 percent, the Spanish Ibex Index rose 0.32 percent, while Italy’s FTSE MIB Index surged 0.44 percent. Meanwhile the German DAX gained 0.61 percent, and the French CAC 40 rose 0.20 percent while U.K. shares rose 0.85 percent.

Economics

U.S. initial jobless claims rose 1,000 from the previous week to reach 260,000 in the latest week. However, economists were expecting claims to reach 265,000 in the week.

U.S. wholesale prices came flat for August, versus economists’ expectations for a 0.1 percent growth.

U.S. retail sales dropped 0.3 percent in August, versus economists’ expectations for a 0.1 percent decline.

The Philadelphia Fed manufacturing index dropped to a reading of 12.8 in September, from 2 in August. Economists expected a reading of 0.8.

The Empire State manufacturing index rose to negative 2 in September, compared to negative 4.2 in August. However, economists were projecting a reading of negative 0.5.

The U.S. current-account deficit dropped 9.1 percent to $119.9 billion in the second quarter.

Industrial production declined 0.4 percent, versus a revised 0.6 percent growth in the previous month. Economists were projecting a 0.2 percent drop.

U.S. business inventories were flat for July, versus economists’ expectations for a 0.10 percent gain.

Supplies of natural gas increased 62 billion cubic feet for the week ended September 9, the U.S. Energy Information Administration reported. Analysts projected a gain of 59 billion to 63 billion cubic feet.

Data on money supply for the latest week will be released at 4:30 p.m. ET.